RAC.AX · RACURA ONCOLOGY LTD
Australia · RS rating 8 · As of 2026-10-14
| Price | 1.60 AUD |
|---|---|
| 1-day change | -0.6% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 13 / 17 / 15 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 18 / 13 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +62.4% |
| Market cap (USD) | $247.6M |